{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CD44s", "CD44v3", "PGG", "cancer stem cell marker", "ubiquitin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36605595", "DateRevised": {"Year": "2023", "Month": "01", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "03"}], "Language": ["eng"], "ELocationID": ["10.1080/19768354.2022.2152864"], "Journal": {"ISSN": "1976-8354", "JournalIssue": {"Volume": "26", "Issue": "6", "PubDate": {"Year": "2022"}}, "Title": "Animal cells and systems", "ISOAbbreviation": "Anim Cells Syst (Seoul)"}, "ArticleTitle": "1,2,3,4,6-Penta-<i>O</i>-galloyl-\u03b2-D-glucose Inhibits CD44v3, a cancer stem cell marker, by regulating its transcription factor, in human pancreatic cancer cell line.", "Pagination": {"StartPage": "328", "EndPage": "337", "MedlinePgn": "328-337"}, "Abstract": {"AbstractText": ["Inhibition of cluster of differentiation 44 (CD44), a pancreatic cancer stem cell (CSC) marker, is a potential treatment for pancreatic ductal adenocarcinoma (PDAC). In this study, we evaluated the effect of 1,2,3,4,6-penta-<i>O</i>-galloyl-\u03b2-D-glucose (PGG), a gallotannin contained in various medicinal plants, on CD44 standard (CD44s) and CD44 variant 3 (CD44v3) in Mia-PaCa-2, human pancreatic cancer cells and explored the underlying mechanisms. PGG showed cytotoxic effects and inhibited the proliferation of Mia-PaCa-2 cells. It also inhibited clonogenic activity, adhesion to fibronectin, and cell migration, which are characteristics of CSCs. PGG inhibited the expression of CD44s and CD44v3 by inducing the phosphorylation of p53 and suppressing NF-\u03baB and Foxo3. Inhibition of Foxo3 induces CD44v3 ubiquitination. Indeed, PGG increased proteasome activity and promoted CD44v3 ubiquitination. PGG downregulated the CSC regulatory factors Nanog, Oct-4, and Sox-2, which act downstream of CD44v3 signaling. These data indicate that PGG may have therapeutic effects in pancreatic cancer mediated by inhibition of CSC markers."], "CopyrightInformation": "\u00a9 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group."}, "AuthorList": [{"Identifier": ["0000-0002-2197-7684"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food and Nutrition, Daegu University, Gyeongsan-si, Republic of Korea."}], "LastName": "Kim", "ForeName": "Eun-Young", "Initials": "EY"}, {"Identifier": ["0000-0002-5965-7416"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food and Nutrition, Daegu University, Gyeongsan-si, Republic of Korea."}], "LastName": "Lee", "ForeName": "Seong-Uk", "Initials": "SU"}, {"Identifier": ["0000-0003-2914-1280"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food and Nutrition, Daegu University, Gyeongsan-si, Republic of Korea."}], "LastName": "Kim", "ForeName": "Yoon Hee", "Initials": "YH"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Anim Cells Syst (Seoul)", "NlmUniqueID": "101478641", "ISSNLinking": "1976-8354"}, "CoiStatement": "No potential conflict of interest was reported by the author(s)."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bae MS, Kim EY, Kim YH.. 2019. Anti-pancreatic cancer effect of 1,2,3,4,6-penta-O-galloyl-b-D-glucose in PANC-1 through inhibition of CD44. J Korean Soc Food Sci Nutr. 48:1440\u20131446."}, {"Citation": "Barati M, Akhondi M, Mousavi NS, Haghparast N, Ghodsi A, Baharvand H, Ebrahimi M, Hassani SN.. 2021. Pluripotent stem cells: cancer study, therapy, and vaccination. Stem Cell Rev Rep. 17:1975\u20131332.", "ArticleIdList": ["PMC8193020", "34115316"]}, {"Citation": "Bourguignon LY, Wong G, Earle C, Chen L.. 2012. Hyaluronan-CD44v3 interaction with Oct4-Sox2- Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem. 287:32800\u201332824.", "ArticleIdList": ["PMC3463333", "22847005"]}, {"Citation": "Cancer.Net\u00ae . 2022. Pancreatic Cancer: Statistics. https://www.cancer.net/cancer-types/pancreatic-cancer/statistics#:~:text\u2009=\u2009The%20general%205-year (accessed February 2022)."}, {"Citation": "Chai Y, Lee HJ, Shaik AA, Nkhata K, Xing C, Zhang J, Jeong SJ, Kim SH, Lu J.. 2010. Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth. Breast Cancer Res. 12:R67.", "ArticleIdList": ["PMC3096953", "20809980"]}, {"Citation": "Chang CH, Pauklin S.. 2021. Extracellular vesicles in pancreatic cancer progression and therapies. Cell Death Dis. 12:973\u2013992.", "ArticleIdList": ["PMC8528925", "34671031"]}, {"Citation": "Chaudhry GES, Akim A, Zafar MN, Safdar N, Sung YY, Muhammad TST.. 2021. Understanding hyaluronan receptor (CD44) interaction, HA-CD44 activated potential targets in cancer therapeutics. Adv Pharm Bull. 11:426\u2013438.", "ArticleIdList": ["PMC8421618", "34513617"]}, {"Citation": "Chen C, Zhao S, Karnad A, Freeman JW.. 2018. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 11:64\u201387.", "ArticleIdList": ["PMC5946470", "29747682"]}, {"Citation": "Chen K, Zhang C, Ling S, Wei R, Wang J, Xu X.. 2021. The metabolic flexibility of quiescent CSC: implications for chemotherapy. Cell Death Dis. 12:835.", "ArticleIdList": ["PMC8418609", "34482364"]}, {"Citation": "Claudia DC, Jessica B, Cecconi D.. 2018. Pancreatic cancer stem cells: perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma. World J Stem Cells. 10:172\u2013182.", "ArticleIdList": ["PMC6325076", "30631392"]}, {"Citation": "Franken AP, Rodermond HM, Jan S, Jaap H, Bree CV.. 2006. Clonogenic assay of cells in vitro. Natureprotocols. 1:2315\u20132319.", "ArticleIdList": ["17406473"]}, {"Citation": "Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, Liu A, Miu K, Watnick RS, Reinhardt F, et al. . 2008. Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell. 134:62\u201373.", "ArticleIdList": ["PMC3222460", "18614011"]}, {"Citation": "Gotte M, Yip GW.. 2006. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res. 66:10233\u201310237.", "ArticleIdList": ["17079438"]}, {"Citation": "Gregory S, Hugo V, Lies G, Baki T.. 2009. Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nature. 6:580\u2013586.", "ArticleIdList": ["19687789"]}, {"Citation": "Guo Q, Yang C, Gao F.. 2021. The state of CD44 activation in cancer progression and therapeutic targeting. FEBS J. Online ahead of print. doi:10.1111/febs.16179.", "ArticleIdList": ["10.1111/febs.16179", "34478583"]}, {"Citation": "Gzil A, Zar\u0119bska I, Bursiewicz W, Antosik P, Grzanka D, Szylberg \u0141. 2019. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications. Mol Biol Rep. 46:6629\u20136645.", "ArticleIdList": ["31486978"]}, {"Citation": "Hong SP, Jing W, Bang SM, Park SW, Song SY.. 2009. CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. Int J Cancer. 125:2323\u20132331.", "ArticleIdList": ["19598259"]}, {"Citation": "Hu H, Lee HJ, Jiang C, Zhang J, Wang L, Zhao Y, Xiang Q, Lee EO, Kim SH, L\u00fc J.. 2008. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Mol Cancer Ther. 7:2681\u20132691.", "ArticleIdList": ["18790750"]}, {"Citation": "Ishiwata T, Matsuda Y, Yoshimura H, Sasaki N, Ishiwata S, Ishikawaet N, Takubo K, Arai T, Aida J.. 2018. Pancreatic cancer stem cells: features and detection methods. Pathol Oncol Res. 24:797\u2013805.", "ArticleIdList": ["29948612"]}, {"Citation": "Jang SE, Hyam SR, Jeong JJ, Han MJ, Kim DH.. 2013. Penta-O-galloyl-beta-D-glucose ameliorates inflammation by inhibiting MyD88/NF-\u03baB and MyD88/MAPK signalling pathways. Br J Pharmacol. 170:1078\u20131091.", "ArticleIdList": ["PMC3949655", "23941302"]}, {"Citation": "Janiszewska M, Primi MC, Izard T.. 2020. Cell adhesion in cancer: beyond the migration of single cells. J Biol Chem. 295:2495\u20132505.", "ArticleIdList": ["PMC7039572", "31937589"]}, {"Citation": "Kawk SH, Kang YR, Kim YH.. 2018. 1,2,3,4,6-Penta-O-galloyl-\u03b2-d-glucose suppresses colon cancer through induction of tumor suppressor. Bioorg Med Chem Lett. 28:2117\u20132123.", "ArticleIdList": ["29778287"]}, {"Citation": "Kim BH, Choi MS, Lee HG, Lee SH, Noh KH, Sunho K, Jeong AJ, Haeri L, Yi EH, Park JY, et al. . 2015. Photoprotective potential of penta-O-galloyl-beta-D glucose by targeting NF-kappaB and MAPK signaling in UVB radiation-induced human dermal fibroblasts and mouse skin. Mol Cells. 38:982\u2013990.", "ArticleIdList": ["PMC4673413", "26537189"]}, {"Citation": "Kumazoe M, Takai M, Bae J, Hiroi S, Huang Y, Takamatsu K, Won Y, Yamashita M, Hidaka S, Yamashita S, et al. . 2016. FOXO3 is essential for CD44 expression in pancreatic cancer cells. Oncogene. 36:2643\u20132654.", "ArticleIdList": ["27893718"]}, {"Citation": "Kuniyasu H, Chihara Y, Kubozoe T, Takahashi T.. 2002. Co-expression of CD44v3 and Heparanase is correlated with metastasis of human colon cancer. Int J Mol Med. 10:333\u2013337.", "ArticleIdList": ["12165810"]}, {"Citation": "Kwon OJ, Bae JS, Lee HY, Hwang JY, Lee EW, Ito H, Kim TH.. 2013. Pancreatic lipase inhibitory gallotannins from galla rhois with inhibitory effects on adipocyte differentiation in 3T3-L1 cells. Molecules. 18:10629\u201310638.", "ArticleIdList": ["PMC6269876", "24002138"]}, {"Citation": "Lee HW, Kang YR, Bae MS, Kim YH.. 2017. Anti-inflammatory effects of 1,2,3,4,6-penta-O-galloyl-b-D-glucose in LPS-stimulated macrophages. J Korean Soc Food Sci Nutr. 46:409\u2013416."}, {"Citation": "Lee JE, Lim YH, Kim JH.. 2021. UCH-1 and UCH-L3 regulate the cancer stem cell-like properties through PI3K/Akt signaling pathway in prostate cancer cells. Anim Cells Syst (Seoul). 25(5):312\u2013322.", "ArticleIdList": ["PMC8567960", "34745437"]}, {"Citation": "Li L, Hao X, Qin J, Tang W, He F, Smith A, Zhang M, Simeone DM, Qiao XT, Chen ZN, et al. . 2014. Antibody against CD44s inhibits pancreatic tumor initiation and post-radiation recurrence in mice. Gastroenterol. 146:1108\u20131118.", "ArticleIdList": ["PMC3982149", "24397969"]}, {"Citation": "Lindenboim L, Zohar H, Worman HJ, Stein R.. 2020. The nuclear envelope: target and mediator of the apoptotic process. Cell Death Discov. 6:29.", "ArticleIdList": ["PMC7184752", "32351716"]}, {"Citation": "Mendonca P, Alghamdi S, Messeha S, Soliman KFA.. 2021. Pentagalloyl glucose inhibits TNF-\u03b1-activated CXCL1/GRO-\u03b1 expression and induces apoptosis-related genes in triple-negative breast cancer cells. Sci Rep. 11:5649\u20135662.", "ArticleIdList": ["PMC7952910", "33707603"]}, {"Citation": "Palamaris K, Felekouras E, Sakellariou S.. 2021. Epithelial to mesenchymal transition: key regulator of pancreatic ductal adenocarcinoma progression and chemoresistance. Cancers (Basel). 13:5532.", "ArticleIdList": ["PMC8582651", "34771695"]}, {"Citation": "Patil K, Khan FB, Akhtar S, Ahmad A, Uddin S.. 2021. The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance. Cancer Metastasis Rev. 40:691\u2013720.", "ArticleIdList": ["PMC8556195", "34453639"]}, {"Citation": "Pook H, Pauklin S.. 2021. Mechanisms of cancer cell death: therapeutic implications for pancreatic ductal adenocarcinoma. Cancers (Basel). 13:4834.", "ArticleIdList": ["PMC8508208", "34638318"]}, {"Citation": "Preeti S, Dominic A, Rao RS, Shankargoude P, Awan KH, Sowmya SV, Haragannavar VC, Kacitha P.. 2021. Role of cancer stem cells in head-and-neck squamous cell carcinoma - a systematic review. J Carcinog. 20:12.", "ArticleIdList": ["PMC8511833", "34729044"]}, {"Citation": "Reategui EP, Mayolo AA, Das PM, Astor FC, Singal R, Hamiltor KL, Goodwin WJ, Carraway KL, Franzmann EJ.. 2006. Characterization of CD44v3 containing isoforms in head and neck cancer. Cancer Biol Ther. 5:1163\u20131168.", "ArticleIdList": ["16855392"]}, {"Citation": "Robinson M, Gilbert SF, Waters JA, Lujano-Olazaba O, Lara J, Alexander LJ, Green SE, Burkeen GA, Patrus O, Sarwar Z, et al. . 2021. Characterization of Sox2, Oct4 and NANOG in ovarian cancer tumor-initiating cells. Cancers (Basel). 13:262.", "ArticleIdList": ["PMC7828139", "33445692"]}, {"Citation": "Shayimu P, Yusufu A, Rehemutula A, Redati D, Jiapaer R, Tuerdi R.. 2021. MTBP promoted the proliferation, migration and invasion of colon cancer cells by activation the expression of ZEB2. Anim Cells Syst (Seoul). 25(3):152\u2013160.", "ArticleIdList": ["PMC8253212", "34262658"]}, {"Citation": "Smith SM, Lyu YL, Cai L.. 2014. NF-\u03baB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression. PLoS One. 9:e106966. 1-9.", "ArticleIdList": ["PMC4153718", "25184276"]}, {"Citation": "Tang Z, Xu Z, Zhu X, Zhang J.. 2021. New insights into molecules and pathways of cancer metabolism and therapeutic implications. Cancer Commun(Lond). 41:16\u201336.", "ArticleIdList": ["PMC7819563", "33174400"]}, {"Citation": "To WS, Midwood KS.. 2011. Plasma and cellular Fibronectin: distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair. 4:4\u201321.", "ArticleIdList": ["PMC3182887", "21923916"]}, {"Citation": "Todoroki K, Ogasawara S, Akiba J, Nakayama M, Naito Y, Seki N, Kusukawa J, Yano H.. 2016. CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinoma. IJCO. 48:99\u2013109.", "ArticleIdList": ["PMC4734600", "26647656"]}, {"Citation": "Wang SJ, Wreesmann VB, Bourguignon LW.. 2007. Association of CD44V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Head Neck. 29:550\u2013558.", "ArticleIdList": ["17252589"]}, {"Citation": "Wei CY, Zhu MX, Yang YW, Zhang PF, Xuan Y, Rui P, Chao G, Lu JC, Lu W, Deng XY, et al. . 2019. Downregulation of RNF128 activates Wnt/b-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma. J Hematol Oncol. 12:21.", "ArticleIdList": ["PMC6399928", "30832692"]}, {"Citation": "Wood NJ. 2014. Pancreatic cancer: pancreatic tumour formation and recurrence after radiotherapy are blocked by targeting CD44. Nat Rev Gastro Hepat. 11:73.", "ArticleIdList": ["24445614"]}, {"Citation": "Zhao S, Chen C, Chang K, Karnad A, Jagirdar J, Kumar AP, Freeman JW.. 2016. CD44 expression level and isoform contributes to pancreatic cancer cell plasticity, invasiveness, and response to therapy. Clin Cancer Res. 22:5592\u20135604.", "ArticleIdList": ["PMC5143222", "27267855"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "6", "Hour": "2", "Minute": "37"}, {"Year": "2023", "Month": "1", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "7", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "12", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["36605595", "PMC9809349", "10.1080/19768354.2022.2152864", "2152864"]}}], "PubmedBookArticle": []}